Skip to content

EPAM Systems EPAM Payments for Restructuring

Payments for Restructuring at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$5.72M+2,636%
Whirlpool logo
WhirlpoolWHR
$6M+50.0%
HNI logo
HNIHNI
$10.3M
Q2 Holdings logo
Q2 HoldingsQTWO
$500K+150%
CarGurus, Inc. logo
CarGurus, Inc.CARG
$1.2M
Repligen logo
RepligenRGEN
$399K

Other financials

Income statement

See full
Revenue$1.4B+7.6%
Gross profit$388.0M+11.0%
Operating income$116.8M+17.6%
Net income$82.5M+12.3%
EPS (diluted)$1.52+18.8%

Balance sheet

See full
Cash & equivalents$1.0B-11.5%
Total debt$287.9M+82.1%
Total equity$3.4B-5.8%
Total assets$4.7B-0.4%

Cash flow

See full
Operating cash flow-$36.4M-250%
CapEx$17.9M+91.4%
Free cash flow-$54.2M-466%

Valuation

See full
Market cap$4.02B-23.7%

Profitability

See full
Gross margin29%-1.2pp
Operating margin9.7%-1.3pp
Net margin7%-1.5pp
FCF margin9.8%+1.2pp

Returns & leverage

See full
Return on equity10.9%-0.6pp
Debt / equity0.1×0.0×
Current ratio2.7×-0.4×

Where this comes from

Reported directly by EPAM Systems in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRestructuring.

The official record: EPAM Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EPAM Systems's payments for restructuring.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EPAM Systems's payments for restructuring?
EPAM Systems (EPAM) reported payments for restructuring of $12.64M in Q1 2026.
How has EPAM Systems's payments for restructuring changed year-over-year?
EPAM Systems's payments for restructuring increased by 149.7% year-over-year, from $5.06M to $12.64M.